Clarus Ventures, LLC - Q4 2023 holdings

 Value Shares↓ Weighting
No holdings reported for quarter Q4 2023
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Nanostring Technologies Inc.20Q3 201860.2%
Sientra Inc.16Q3 201838.2%
Oxford Immunotex Global PLC14Q1 201717.4%
Catabasis Pharmaceuticals Inc.14Q3 201815.3%
VBI Vaccines Inc.10Q3 201811.4%
TetraLogic Pharmaceuticals Corporation9Q4 201512.5%
ESSA Pharma Inc.9Q1 20186.5%
Aerie Pharmaceuticals Inc.7Q4 201530.5%
VBI Vaccines Inc.7Q1 20169.1%
Ophthotech Corp6Q1 201531.5%

View Clarus Ventures, LLC's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-NT2024-08-14
13F-NT2024-05-15
13F-NT2024-02-14
13F-NT2023-11-14
13F-NT2023-08-14
13F-NT2023-05-15
13F-NT2023-02-14
13F-NT2022-11-14
13F-NT2022-08-15

View Clarus Ventures, LLC's complete filings history.

Compare quarters

Export Clarus Ventures, LLC's holdings